What You Should Know
- Pomelo Care has closed a $92 million Series C funding round, propelling the company to a $1.7B valuation.
- After proving its virtual model can reduce preterm births by 37% and emergency room visits by 46%, Pomelo is moving beyond its maternity roots to launch comprehensive pediatric and midlife care programs, now covering more than 25 million lives nationwide.
The Accountability Pivot: Evidence Over Hype
In a 2026 market where "Agentic AI" and "Digital
Read More
Topos Bio Emerges from Stealth to Tackle Disordered Proteins with $10.5M and Frontier AI
What You Should Know
- Topos Bio has emerged from stealth with $10.5M in seed funding to solve one of the most persistent challenges in medicine: targeting intrinsically disordered proteins (IDPs). The seed funding was led by Boldstart, Threshold, and Neo, with participation from notable angel investors including Dara Khosrowshahi (CEO of Uber) and Naveen Rao (CEO of Unconventional AI).
- While traditional models like AlphaFold focus on static structures, Topos Bio’s foundation model,
Read More
Carna Health Raises $8M to Scale Global AI-Driven Kidney Screening
What You Should Know
- Carna Health has raised $8M to scale its AI-driven Cardio-Kidney-Metabolic (CKM) platform. The round included participation from Dr. Jay Rosan, Cenk Bekmezçi, Jose Pereyra, Mark Boulding, Brandon Salomon, Andrew Roosevelt, Jeff Lindsey, Joseph White, John Brooks, Elvis Ndansi and Dr. Salvatore Viscomi.
- Following a successful initiative in Cameroon that screened 35,000 individuals, Carna is expanding its partnership with Siemens Healthineers to bring
Read More
Inova Health Partners with Notable to Scale ‘Agentic’ RCM and Referral Automation
What You Should Know
- Inova Health, a non-profit provider in Northern Virginia, has announced a strategic partnership with Notable to deploy an integrated AI platform across its revenue cycle and patient access operations.
- By utilizing "Agentic AI"—autonomous agents that execute multi-step workflows—Inova aims to reclaim 80% of staff time lost to manual documentation requests and reduce orthopedic referral leakage by 20%.
How Notable's AI Platform Automates High-Friction
Read More
Women’s Health Crisis Revealed: 68% Don’t Trust Their OB/GYN, Report Finds
What You Should Know:
- O Positiv Health has released its 2026 State of the Vagina Report, a survey of over 3,000 women that exposes profound deficits in health literacy and provider trust. The data reveals that 96% of women cannot identify the phases of their menstrual cycle, while a startling 68% explicitly lack trust in their OB/GYNs, leading many to skip annual appointments entirely.
- The report underscores how deep-seated stigma and educational gaps are driving dangerous hygiene
Read More
Healthconnect Texas and PCIC Unify to Build the Ultimate Social Drivers of Health (SDoH) Infrastructure
What You Should Know
- Healthconnect Texas and the Patient Care Intervention Center (PCIC) have announced a strategic unification, merging statewide clinical connectivity with deep community-based data on non-medical drivers of health.
- The unified infrastructure aims to provide a "360-degree view" of patient wellness, enabling providers and policymakers to address the 80-90% of health outcomes driven by lifestyle and environmental factors that typically live outside the Electronic
Read More
How Medable’s Agentic AI TMF Solves the Clinical Trial ‘Clerical Debt’ Problem
What You Should Know
- Medable has announced its TMF Agent, a first-of-its-kind agentic AI tool designed to automate the labor-intensive Trial Master File (TMF) process at JPM 2026. It automates 95% of manual document workflows, ingesting and classifying files for Veeva Vault and OpenText.
- By reducing the administrative burden that consumes 33% of a CRA's time, Medable enables "one-day study starts" while maintaining human-in-the-loop (HITL) compliance and audit traceability.
The
Read More
Beyond the Sensor: How January AI’s Food Scanner Replaces CGM Friction for GLP-1 Care
What You Should Know
- January AI has transitioned its science-validated "virtual glucose monitor" technology into a suite of Enterprise APIs, enabling B2B partners to embed AI-powered food recognition and glucose prediction into their own platforms.
- This move allows health systems and longevity companies to turn underutilized lifestyle signals—like photos and wearable data—into structured, metabolic insights at scale.
The "Context Gap": Why Lifestyle Data Often
Read More
Abbott Debuts GenAI ‘Libre Assist’ to Tackle Mealtime Decision Fatigue
What You Should Know:
- Launched at CES 2026, Abbott’s Libre Assist,is a generative AI feature within the Libre app that predicts glucose impact before consumption.
- Using a color-coded rating (Green/Yellow/Orange), it acts as a "digital twin" for nutrition. The system then "closes the loop" by reconciling its prediction against real-world data from the Libre 3 Plus sensor, providing a medically validated feedback loop.
The Technical Architecture
Libre Assist can be
Read More
The $149 Disruptor: GoodRx WeightWatchers, LifeMD Aggressively Scale Access to FDA-Approved Wegovy Pill
What You Should Know:
- The healthcare landscape is witnessing a seismic shift in obesity care as GoodRx, WeightWatchers LifeMD launch the newly FDA-approved Wegovy pill (oral semaglutide) with a transparent cash-pay price of $149 per month.
- By combining 16.6% mean weight loss efficacy with a vast retail and telehealth infrastructure, this rollout effectively removes the twin barriers of injection hesitancy and opaque "middleman" pricing.
Breaking the Injection Barrier: The
Read More
